Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT06407102 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Collection of Primary Human

Study acronym: BIONOSE
StatusRecruiting
PhaseNot applicable
Started2024-12-06
View on ClinicalTrials.gov ↗

Amendment history

2026-06-12
Not Yet Recruiting→Recruiting Study Status, Contacts/Locations v2
Trial statusNot Yet Recruiting→Recruiting
Start dateestimated 2024-06-30→confirmed 2024-12-06
Study sites0→1
2024-05-31
Study Status, Conditions, Outcome Measures v1
Start date2024-05-02→2024-06-30
Primary endpoints1 entry, revised
ViabilityPercentage of viability of nasal epithelial cells from the operating room to laboratory
2024-05-06
Original filing
Treatment and prevention of respiratory infections are of great interest in many medical areas. Create a physical device covered by primary human nasal cells could be very usefull in order to analyse delivery and efficiency of drugs. In this context the aim of this project is to create a collection of primary cells from the human nasal epithelium. This collection will be realised during programmed surgery, thanks to a specific device dedicated to collect nasal cells. Then the cells will be sent to the lab in order to grow at the air-liquid interface, which is an excellent 'ex vivo' model for their study.
Trial Details
NCT Number NCT06407102
Lead Sponsor University Hospital, Tours
Conditions Nasal Disease
Enrollment 100 participants
Start Date 2024-12-06
Primary Completion 2027-05-02 (estimated)
Study Completion 2028-05-02 (estimated)
Updated on ClinicalTrials.gov 2026-06-16